Blood Platelets Market Size to Reach USD 8.04 Billion by 2035 | Sysmex Corporation Leads with 23.1% Market Share | North America Dominates with 41.3% Share

The global Blood Platelets market was valued at USD 4.71 billion in 2025 and is projected to reach USD 8.04 billion by 2035, expanding at a CAGR of 5.5% during the forecast period from 2026 to 2035. The market has emerged as a strategic investment opportunity within the transfusion medicine and regenerative healthcare sectors, driven by rising demand for platelet transfusions in hematology, oncology, trauma care, and complex surgical procedures. Increasing incidence of cancer, blood disorders, and chemotherapy-induced thrombocytopenia, along with the expanding use of platelet-rich plasma (PRP) therapies in orthopedics, dermatology, dentistry, and aesthetic medicine, is creating sustained demand for platelet products. Investors are increasingly focusing on companies developing advanced platelet collection, storage, pathogen reduction, and processing technologies to improve product safety, availability, and clinical outcomes.

Investment momentum continues to strengthen as blood banks, biotechnology companies, healthcare providers, and medical technology firms expand platelet production and distribution capabilities through innovation and strategic collaborations. Advancements in automated apheresis systems, pathogen inactivation technologies, cold-stored platelets, and next-generation platelet preservation solutions are improving supply efficiency and extending product usability. Growing demand for platelet therapies across hospitals, trauma centers, cancer treatment facilities, and regenerative medicine clinics is creating significant commercial opportunities worldwide. As healthcare systems continue to strengthen blood management programs and invest in advanced transfusion technologies, the blood platelets market is expected to remain a strategic investment segment supporting the future of emergency care, oncology, and regenerative medicine.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/blood-platelets-market?sai-v

Key Developments

June 2026: Terumo Blood and Cell Technologies expanded its blood platelet collection portfolio by introducing advanced apheresis technologies designed to improve platelet collection efficiency, donor comfort, and the availability of high-quality platelet components for transfusion medicine.

May 2026: Fresenius Kabi strengthened its transfusion medicine business by enhancing blood component processing and platelet storage solutions, supporting improved platelet quality, extended usability, and operational efficiency for blood banks and hospitals.

April 2026: Haemonetics advanced its blood management portfolio by expanding automated platelet collection and donor management technologies, enabling higher collection yields and optimized workflows for blood centers.

March 2026: Macopharma enhanced its blood component processing solutions by introducing advanced platelet preparation, storage, and pathogen reduction technologies, improving transfusion safety and supporting the growing demand for platelet therapies.

February 2026: Cerus Corporation expanded its blood safety portfolio by advancing pathogen reduction technologies for platelet concentrates, helping blood banks and healthcare providers improve transfusion safety, reduce transfusion-transmitted infections, and ensure a reliable supply of safe platelet products.

Key Players
Sysmex Corporation | EmCyte Corporation | Eurobio Scientific | Haemochrom Diagnostica GmbH | Aggredyne Inc. | Others

Key Highlights
Sysmex Corporation - Holds a 23.1% share, driven by its advanced hematology analyzers, platelet diagnostics technologies, automated blood testing systems, and strong global presence in clinical laboratory solutions.

EmCyte Corporation - Holds a 18.4% share, supported by its platelet-rich plasma (PRP) technologies, blood component separation systems, regenerative medicine solutions, and expanding portfolio of platelet processing products.

Eurobio Scientific - Holds a 15.6% share, strengthened by its specialized in vitro diagnostic solutions, transfusion medicine products, platelet testing technologies, and extensive distribution network across healthcare laboratories.

Haemochrom Diagnostica GmbH - Holds a 13.2% share, fueled by its expertise in hemostasis and platelet function diagnostics, coagulation testing systems, and comprehensive laboratory diagnostic solutions.

Aggredyne Inc. - Holds a 11.1% share, driven by its innovative platelet function testing platforms, rapid diagnostic technologies, point-of-care solutions, and focus on improving platelet quality assessment.

Others - Hold a combined 18.6% share, comprising Haemonetics Corporation, Terumo Blood and Cell Technologies, Fresenius Kabi, Macopharma, Grifols, and other manufacturers developing platelet collection systems, storage technologies, transfusion medicine products, and advanced platelet diagnostics.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/download-sample/blood-platelets-market?sai-v

Market Drivers
Increasing prevalence of cancer, blood disorders, trauma cases, and surgical procedures, along with rising demand for transfusion therapies, is driving the growth of the blood platelets market.

Growing adoption of apheresis platelet collection, pathogen reduction technologies, advanced blood banking systems, and platelet storage solutions is accelerating market expansion.

Continuous advancements in platelet preservation technologies, automated blood collection systems, artificial intelligence (AI), and blood inventory management are improving platelet availability, transfusion safety, and operational efficiency.

Rising government initiatives for blood donation, expanding healthcare infrastructure, increasing awareness of voluntary blood donation, and growing investments in transfusion medicine are supporting long-term market growth.

Market Opportunities
Growing demand for platelet transfusions in oncology, hematology, trauma care, organ transplantation, and regenerative medicine is creating significant growth opportunities.

Increasing investments in blood banks, automated collection technologies, pathogen inactivation systems, cold chain logistics, and advanced transfusion services are expanding revenue potential across global markets.

Continuous advancements in synthetic platelets, extended platelet storage technologies, AI-enabled blood inventory management, and next-generation collection systems are opening new avenues for innovation.

Strategic collaborations among blood banks, hospitals, biotechnology companies, diagnostic laboratories, and healthcare organizations are accelerating product development and global market expansion.

Industry Developments
Rapid advancements in apheresis technologies, platelet storage systems, pathogen reduction technologies, automated blood processing, and transfusion management solutions are transforming the blood platelets industry.

Increasing integration of AI, cloud-based blood inventory systems, predictive analytics, digital donor management platforms, and automated laboratory technologies is improving transfusion efficiency, blood availability, and patient safety.

Strategic partnerships, mergers, acquisitions, regulatory approvals, expansion of blood collection centers, and investments in transfusion medicine are strengthening global market competitiveness.

Continuous investments in R&D, next-generation platelet preservation technologies, advanced blood collection systems, regenerative medicine applications, and innovative transfusion solutions are supporting long-term market expansion.

Regional Insights
North America 41.3% share: Leads the market with a 41.3% share due to advanced healthcare infrastructure, high blood donation rates, widespread adoption of apheresis technologies, and the presence of leading blood banking and biotechnology companies.

Europe 29.2% share: Growth is supported by a 29.2% market share, driven by well-established transfusion services, strong government support for blood donation programs, advanced healthcare systems, and increasing demand for platelet therapies.

Asia Pacific 22.1% share: Fastest-growing region with a 22.1% share, driven by expanding healthcare infrastructure, increasing cancer and trauma cases, growing awareness of blood donation, and rising investments across China, India, Japan, and South Korea.

Latin America 4.3% share: Holds a 4.3% share, supported by improving blood banking infrastructure, increasing healthcare investments, expanding voluntary blood donation initiatives, and growing demand for transfusion services.

Middle East & Africa 3.1% share: Accounts for a 3.1% share, driven by expanding healthcare infrastructure, increasing government investments in blood transfusion services, growing awareness of blood donation, and rising adoption of advanced blood banking technologies.

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/blood-platelets-market?sai-v

Key Segments
➥ By Platelet Type

Whole-Blood-Derived Platelets: Represents the dominant segment, driven by widespread availability through conventional blood donation and extensive use in routine transfusion practices.

Apheresis-Derived Platelets: Represents the fastest-growing segment, supported by higher platelet yield, reduced donor exposure, and increasing preference for single-donor platelet transfusions.

➥ By Application

Hemophilia: Represents a significant segment, driven by the need for platelet support in patients with bleeding complications and complex hematological conditions.

Platelet Function Disorder: Represents a substantial segment, supported by increasing diagnosis of inherited and acquired platelet dysfunction requiring transfusion therapy.

Thrombocytopenia: Represents the dominant segment, fueled by the rising prevalence of cancer, chemotherapy-induced thrombocytopenia, bone marrow disorders, and hematological diseases.

Perioperative Indication: Represents a rapidly growing segment, driven by increasing surgical procedures, trauma cases, and demand for platelet transfusions to reduce perioperative bleeding risks.

➥ By End User

Hospitals: Represents the dominant segment, driven by high volumes of emergency care, surgeries, oncology treatments, and transfusion services.

Ambulatory Surgical Centers (ASCs): Represents a growing segment, supported by the increasing number of outpatient surgical procedures requiring perioperative platelet support.

Blood Banks: Represents a significant segment, fueled by expanding platelet collection, processing, storage, and distribution activities.

Others: Represents a moderate segment, driven by increasing utilization across specialty clinics, research institutes, and military healthcare facilities.

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.